Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Cancer”

4,873 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,873 results

Early research (Phase 1)Ended earlyNCT03956056
What this trial is testing

Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Who this might be right for
Pancreas CancerPancreatic CancerCancer of the Pancreas
Washington University School of Medicine 12
Testing effectiveness (Phase 2)Looking for participantsNCT06467565
What this trial is testing

NALIRIFOX as Induction Therapy in LAPC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 20
Early research (Phase 1)Ended earlyNCT04807972
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis

Who this might be right for
Pancreatic Cancer
AbbVie 40
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Early research (Phase 1)Study completedNCT05396300
What this trial is testing

A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerEsophageal CancerStomach Cancer+3 more
Weijia Fang, MD 43
Testing effectiveness (Phase 2)Study completedNCT01303029
What this trial is testing

Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 120
Not applicableStudy completedNCT04660695
What this trial is testing

Nasobiliary Drain Assisted EUS-guided Gastroenterostomies in Unresectable Malignant Gastric Outlet Obstruction

Who this might be right for
Gastric Outlet ObstructionGastric CancerPancreatic Cancer
Hospital del Rio Hortega 66
Early research (Phase 1)Study completedNCT00352131
What this trial is testing

Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors

Who this might be right for
Non-colorectal CancerPancreatic Cancer
ImmunoGen, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00333502
What this trial is testing

Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors

Who this might be right for
CancerSolid Tumor
NewLink Genetics Corporation 62
Not applicableStudy completedNCT05266300
What this trial is testing

Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.

Who this might be right for
Adverse Drug EventColon CancerBreast Cancer+5 more
University of Southern Denmark 722
Not applicableStudy completedNCT04776837
What this trial is testing

Predicting Disease Progression and/or Recurrence in Cancer

Who this might be right for
Patient Reported Outcome MeasuresColorectal CancerPancreatic Cancer+5 more
Massachusetts General Hospital 200
Not applicableWithdrawnNCT04034745
What this trial is testing

Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain

Who this might be right for
Pancreatic CancerNeuroendocrine TumorsCachexia; Cancer
Andrew Hendifar, MD
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Not applicableStudy completedNCT01859806
What this trial is testing

Isolated Roux Loop Pancreaticojejunostomy Versus Pancreaticogastrostomy After Pancreaticoduodenectomy

Who this might be right for
Pancreatic Fistula After Pancreaticoduodenectomy
Mansoura University 80
Early research (Phase 1)Not Yet RecruitingNCT06203821
What this trial is testing

Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Aram Hezel 25
Testing effectiveness (Phase 2)Study completedNCT00514163
What this trial is testing

GEM vs GEM+TS-1 for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Japan Clinical Cancer Research Organization 110
Not applicableUnknownNCT03763214
What this trial is testing

PTFE Stents for Treatment of Malignant Biliary Strictures

Who this might be right for
Bile Duct StrictureBile Duct CancerPancreas Cancer
Johannes Vermehren 64
Not applicableLooking for participantsNCT06147414
What this trial is testing

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Who this might be right for
Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, IncludingSickle Cell DiseaseCystic Fibrosis+12 more
Assistance Publique - Hôpitaux de Paris 550
Not applicableLooking for participantsNCT06494514
What this trial is testing

NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Cancer
Du Juan 40
Very early researchNot Yet RecruitingNCT06156267
What this trial is testing

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

Who this might be right for
Pancreatic Cancer
Fudan University 30
Load More Results